Clinical trial
Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of…
NCT00500071 · Shire, Industry · Completed
Key facts
| NCT number | NCT00500071 |
|---|---|
| Title | Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD |
| Official title | A Prospective, Open-Label, Multi-Center, Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) 20-70mg in Children Aged 6-12 Diagnosed With ADHD |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder (ADHD) |
| Intervention type | Drug |
| Interventions | Vyvanse (lisdexamfetamine dimesylate) |
| Enrollment | 318 |
| Start date | Jun 28, 2007 |
| Primary completion | Jan 2, 2008 |
| Completion | Jan 2, 2008 |
| First posted | Jul 12, 2007 |
| Last update posted | Mar 10, 2022 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: